Indietro

IQVIA Holdings Inc

Ticker: IQV ISIN: US46266C1053
Aggiungi al portafoglio Analisi del portafoglio in 2min
Stock Large-cap High beta Trading above 200-day average Near 52-week high
Capitalizzazione
37,85 Mld $
P/E
30,57
Forward P/E
16,98
Profit margin
8,07%
Revenue growth QoQ
5,20%
Beta
1,37
260,24 $ 0,16%
Prezzo al 2026-08-24 · NYSE

Performance per periodo

Rendimenti cumulativi
1 Month +22,05%
6 Months +57,84%
1 Year +38,41%
5 Years +0,14% p.a.+0,68%
10 Years +12,90% p.a.+236,14%
Since inception +14,69% p.a.+518,00%
Rendimenti per anno
YTD +15,45%
2025 +14,71%
2024 -15,07%
2023 +12,93%
2022 -27,38%
2021 +57,47%

Key stats

Market cap
37,85 Mld
P/E
30,57
Beta
1,37
52-week range
134.65 - 234.30
50-day MA
216,12
200-day MA
181,12
Section 1

Business overview

Company profile data from fundamentals.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.

Sector Healthcare
Industry Diagnostics & Research
Country United States
Exchange NYSE
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 19,37%
ROA 5,07%
Profit margin 8,07%
Operating margin 13,98%
PEG ratio 0,94
Revenue/share TTM 91,31
Revenue TTM 15,90 Mld
EBITDA 2,93 Mld
Gross profit TTM 5,37 Mld
Beta 1,37

Valuation

Trailing P/E 30,57
Forward P/E 16,98
P/B 6,14
P/S 2,38
EV/EBITDA 14,87
EV/Revenue 3,21

ESG Scores

Total ESG 26,8
Environment 1,2
Social 14,8
Governance 6,9
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 11,89
Quarterly earnings growth 24,50%
Revenue TTM 15,90 Mld
Reported quarters 52
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0,00%
Last split date 0000-00-00
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 250,00 $
Analyst rating 4.3044

Ownership & short interest

Shares outstanding 170,30 Mln
Shares float 161,74 Mln
Institutional ownership 100,61%
Insider ownership 1,05%
Short ratio 3,65
Short % of float 3,78%

Details

Instrument metadata and source update timestamps.

Symbol IQV
Name IQVIA Holdings Inc
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US46266C1053
Country USA
Code + exchange IQV.NYSE
Fundamentals updated 2025-12-15

Le informazioni fornite su questa piattaforma hanno solo scopo informativo e non devono essere considerate consulenza finanziaria o di investimento. Insightfolio non fornisce consulenza d'investimento, raccomandazioni personalizzate o indicazioni relative all'acquisto, alla detenzione o alla vendita di strumenti finanziari. Gli strumenti e i contenuti sono destinati esclusivamente a finalita educative e non sono adattati alle circostanze individuali, alle esigenze finanziarie o agli obiettivi personali.

Insightfolio non si assume alcuna responsabilita per l'accuratezza, la completezza o l'affidabilita delle informazioni presentate. Gli utenti sono gli unici responsabili della verifica delle informazioni e dell'assunzione di decisioni indipendenti basate sulla propria ricerca e su un'attenta valutazione. L'uso della piattaforma non deve sostituire la consulenza di professionisti finanziari qualificati.

Gli investimenti comportano rischi. Gli utenti devono essere consapevoli che il valore degli investimenti puo variare e che i rendimenti passati non sono indicativi di risultati futuri. Le decisioni di investimento devono basarsi sugli obiettivi finanziari personali, sulla tolleranza al rischio e su una valutazione indipendente delle informazioni rilevanti.

Insightfolio non approva ne garantisce l'idoneita di alcun prodotto finanziario, titolo o strategia specifica. Eventuali proiezioni, previsioni o scenari ipotetici presentati sulla piattaforma hanno solo scopo illustrativo e non costituiscono garanzia di risultati futuri.

Accedendo ai servizi, alle informazioni o ai contenuti offerti da Insightfolio, gli utenti riconoscono e accettano i presenti termini di esclusione di responsabilita. Se non accetti questi termini, ti invitiamo a non utilizzare la piattaforma.

Instrument logos provided by Elbstream.